CAS 75607-67-9
:Fludarabine phosphate
Description:
Fludarabine phosphate is an antineoplastic agent primarily used in the treatment of certain types of leukemia, particularly chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma. It is a purine analog, specifically a derivative of adenosine, which interferes with DNA synthesis and repair, ultimately leading to cell death. The compound is typically administered intravenously and is known for its ability to penetrate cell membranes effectively due to its phosphate ester form, which enhances its solubility. Fludarabine phosphate exhibits a relatively short half-life, necessitating careful dosing and monitoring during treatment. Common side effects include myelosuppression, immunosuppression, and gastrointestinal disturbances. Its mechanism of action involves the inhibition of DNA polymerase and ribonucleotide reductase, disrupting the proliferation of malignant cells. As a chemotherapeutic agent, it is often used in combination with other drugs to enhance therapeutic efficacy. Due to its potent effects, fludarabine phosphate is classified as a hazardous drug, requiring appropriate handling and disposal measures in clinical settings.
Formula:C10H13FN5O7P
InChI:InChI=1S/C10H13FN5O7P/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(18)5(17)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,17-18H,1H2,(H2,12,14,15)(H2,19,20,21)/t3-,5-,6+,9-/m1/s1
InChI key:InChIKey=GIUYCYHIANZCFB-FJFJXFQQSA-N
SMILES:NC1=C2C(N(C=N2)[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]3O)=NC(F)=N1
Synonyms:- 9-bata-D-Arabinofuranosyl-2-fluoroadenine phosphate
- 9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-β-D-arabinofuranosyl)-
- 9-b-D-Arabinofuranosyl-2-fluoroadenine-5-(dihydrogen phosphate)
- 2-Fluoro-9-(5-O-phosphono-β-D-arabinofuranosyl)-9H-purin-6-amine
- Fludarabine phosphate
- Fludarabin Phosphate
- NSC 312887
- NSC 328002
- 9-beta-arabinofuranosyl-2-fluoroadenine-5'-phosphate
- 2-fluoro-9-(5-O-phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine
- 9-β-Arabinofuranosyl-2-fluoroadenine-5'-monophosphate
- 2-fluoro-9-(5-O-phosphonopentofuranosyl)-9H-purin-6-amine
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 17 products.
Fludarabine Monophosphate
CAS:Formula:C10H13FN5O7PPurity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:365.21Fludarabine phosphate
CAS:Fludarabine phosphateFormula:C10H13FN5O7PPurity:97.8%Color and Shape:White. To. Off-WhiteMolecular weight:365.05366FLUDARABINE PHOSPHATE CRS
CAS:<p>FLUDARABINE PHOSPHATE CRS</p>Formula:C10H13FN5O7PColor and Shape:Added AddedMolecular weight:365.2117Fludarabine Phosphate
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C10H13FN5O7PColor and Shape:White Crystalline PowderMolecular weight:365.05366{[(2R,3S,4S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid
CAS:Formula:C10H13FN5O7PPurity:98%Color and Shape:SolidMolecular weight:365.2117Fludarabine Phosphate
CAS:Formula:C10H13FN5O7PColor and Shape:White To Off-White SolidMolecular weight:365.22Fludarabine phosphate, USP
CAS:Formula:C10H13FN5O7PPurity:≤ 0.1%Color and Shape:White powderMolecular weight:365.21Fludarabine Phosphate
CAS:<p>Fludarabine Phosphate (NSC 312887 Phosphate) is a fluorinated nucleotide antimetabolite analog of the antiviral agent vidarabine with antineoplastic activity.</p>Formula:C10H13FN5O7PPurity:99.25% - 99.78%Color and Shape:SolidMolecular weight:365.21Fludarabine phosphate
CAS:Formula:C10H13FN5O7PPurity:≥ 98.0%Color and Shape:White to almost white powderMolecular weight:365.21Fludarabine Phosphate
CAS:Controlled Product<p>Applications 4-Desfluoro-4-(1,2,4-triazol-1-yl)phenyl Fluconazole is an impurity in the synthesis of Fluconazole (F421000), used as an antifungal.<br>References Richard, K. et al.: Antimicrob. Ag. Chemother., 27, 832 (1985);<br></p>Formula:C10H13FN5O7PColor and Shape:White To Off-WhiteMolecular weight:365.21Fludarabine phosphate
CAS:<p>Fludarabine phosphate is an antileukemic drug that inhibits DNA polymerase α and β, as well as other enzymes in the nucleotide synthesis pathway. It is used to treat patients with chronic myelogenous leukemia (CML) who have developed resistance to other treatments. Fludarabine phosphate has been shown to induce a cytotoxic effect against tumor cells by binding to ATP-binding cassette transporter proteins on the cell membrane and inhibiting intracellular targets such as DNA, RNA, and protein synthesis. Fludarabine phosphate has also been shown to inhibit the growth of tumor cells through synergistic interactions with other anticancer drugs such as hydroxyurea or busulfan, which may be due to its ability to inhibit enzyme activities such as erythrocyte alkaline phosphatase.</p>Formula:C10H13FN5O7PPurity:Min. 98 Area-%Color and Shape:PowderMolecular weight:365.21 g/mol













